WO2002039109A3 - Procede de detection de cellules hematopoietiques humaines capables de reconstitution a court terme - Google Patents

Procede de detection de cellules hematopoietiques humaines capables de reconstitution a court terme Download PDF

Info

Publication number
WO2002039109A3
WO2002039109A3 PCT/CA2001/001555 CA0101555W WO0239109A3 WO 2002039109 A3 WO2002039109 A3 WO 2002039109A3 CA 0101555 W CA0101555 W CA 0101555W WO 0239109 A3 WO0239109 A3 WO 0239109A3
Authority
WO
WIPO (PCT)
Prior art keywords
short term
cells
strc
term repopulating
repopulating cells
Prior art date
Application number
PCT/CA2001/001555
Other languages
English (en)
Other versions
WO2002039109A2 (fr
Inventor
Connie J Eaves
Hanno Glimm
Original Assignee
British Columbia Cancer Agency
Connie J Eaves
Hanno Glimm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Columbia Cancer Agency, Connie J Eaves, Hanno Glimm filed Critical British Columbia Cancer Agency
Priority to US10/416,147 priority Critical patent/US20040029188A1/en
Priority to AU2002213725A priority patent/AU2002213725A1/en
Priority to CA002428107A priority patent/CA2428107A1/fr
Publication of WO2002039109A2 publication Critical patent/WO2002039109A2/fr
Publication of WO2002039109A3 publication Critical patent/WO2002039109A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne deux nouvelles populations de cellules humaines capables de reconstitution de l'hématopoïèse à court terme. Plus spécifiquement, les inventeurs ont montré que des souris NOD/SCID-β2M-/- irradiées sublétalement permettent la prise de greffe efficace de deux populations de cellules humaines capables de reconstitution de l'hématopoïèse à court terme (STRC) non décrites auparavant, lesquelles cellules ne produisent pas une descendance détectable dans la souris NOD/SCID, plus largement utilisée. Ces nouvelles cellules sont désignées par les termes cellules capables de reconstitution de l'hématopoïèse à court terme myéloïdes (STRC-M) et cellules capables de reconstitution de l'hématopoïèse à court terme lympho-myéloïdes (STRC-ML) afin de refléter leurs différents potentiels de lignée. L'invention comprend un test pour détecter STRC-M et STRC-ML, utile dans une vaste gamme d'applications, notamment pour tester la capacité de prise de greffe de cellules hématopoïétiques humaines, pour tester la toxicité de médicaments sur des cellules hématopoïétiques et pour évaluer la viabilité de cellules hématopoïétiques ayant été stockées et traitées.
PCT/CA2001/001555 2000-11-07 2001-11-07 Procede de detection de cellules hematopoietiques humaines capables de reconstitution a court terme WO2002039109A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/416,147 US20040029188A1 (en) 2000-11-07 2001-11-07 Method for the detection of human hematopoietic short term repopulating cells
AU2002213725A AU2002213725A1 (en) 2000-11-07 2001-11-07 Method for the detection of human hematopoietic short term repopulating cells
CA002428107A CA2428107A1 (fr) 2000-11-07 2001-11-07 Procede de detection de cellules hematopoietiques humaines capables de reconstitution a court terme

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24608200P 2000-11-07 2000-11-07
US60/246,082 2000-11-07

Publications (2)

Publication Number Publication Date
WO2002039109A2 WO2002039109A2 (fr) 2002-05-16
WO2002039109A3 true WO2002039109A3 (fr) 2003-05-01

Family

ID=22929252

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2001/001555 WO2002039109A2 (fr) 2000-11-07 2001-11-07 Procede de detection de cellules hematopoietiques humaines capables de reconstitution a court terme

Country Status (4)

Country Link
US (1) US20040029188A1 (fr)
AU (1) AU2002213725A1 (fr)
CA (1) CA2428107A1 (fr)
WO (1) WO2002039109A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013116307A1 (fr) 2012-01-30 2013-08-08 Mount Sinai School Of Medicine Méthode de programmation de cellules différenciées en cellules souches hématopoïétiques
CN114791502B (zh) * 2022-06-13 2022-10-28 深圳市帝迈生物技术有限公司 一种样本检测方法以及样本分析仪

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999023205A1 (fr) * 1997-10-31 1999-05-14 Hsc Research And Development Limited Partnership Cellules souches hematopoietiques

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999023205A1 (fr) * 1997-10-31 1999-05-14 Hsc Research And Development Limited Partnership Cellules souches hematopoietiques

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BHATIA M ET AL: "A newly discovered class of human hematopoietic cells with SCID-repopulating activity [see comments]", NATURE MEDICINE, NATURE PUBLISHING, CO, US, vol. 4, no. 9, 1 September 1998 (1998-09-01), pages 1038 - 1045, XP002097293, ISSN: 1078-8956 *
GLIMM H ET AL: "Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice.", THE JOURNAL OF CLINICAL INVESTIGATION. UNITED STATES JAN 2001, vol. 107, no. 2, January 2001 (2001-01-01), pages 199 - 206, XP002223073, ISSN: 0021-9738 *
KOLLET O ET AL: "beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function.", BLOOD. UNITED STATES 15 MAY 2000, vol. 95, no. 10, 15 May 2000 (2000-05-15), pages 3102 - 3105, XP002223072, ISSN: 0006-4971 *
LAROCHELLE ET AL: "Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy", NATURE MEDICINE, NATURE PUBLISHING, CO, US, vol. 2, no. 12, December 1996 (1996-12-01), pages 1329 - 1337, XP002127668, ISSN: 1078-8956 *

Also Published As

Publication number Publication date
AU2002213725A1 (en) 2002-05-21
CA2428107A1 (fr) 2002-05-16
WO2002039109A2 (fr) 2002-05-16
US20040029188A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
Linnakoski et al. Antiviral agents from fungi: diversity, mechanisms and potential applications
Mayer et al. Disarming fungal pathogens: Bacillus safensis inhibits virulence factor production and biofilm formation by Cryptococcus neoformans and Candida albicans
Mosel et al. Farnesol concentrations required to block germ tube formation in Candida albicans in the presence and absence of serum
Adagu et al. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis
DE60132429D1 (de) Pluripotente stammzellen erzeugt aus stromalzellen aus dem fettgewebe und deren verwendungen
Ribas et al. Effects of anti-inflammatory drugs in primary kidney cell culture of a freshwater fish
MXPA04000062A (es) Miembros de drenaje extensibles para conectar a tierra la proteccion por interferencia electromagnetica/interferencia por radiofrecuencia.
CA2066561A1 (fr) Methodes de detection rapide des microorganismes
Vendetti et al. The introduced terrestrial slugs Ambigolimax nyctelius (Bourguignat, 1861) and Ambigolimax valentianus (Férussac, 1821)(Gastropoda: Limacidae) in California, with a discussion of taxonomy, systematics, and discovery by citizen science
Konstantinovas et al. Modulation of human immune response by fungal biocontrol agents
Wassermann et al. Examination of Sarcocystis spp. of giant snakes from Australia and Southeast Asia confirms presence of a known pathogen–Sarcocystis nesbitti
Moore Jr Mid-Tertiary evolution of the radiolarian genus Calocycletta
Setiawan et al. Fungicide activity of culture extract from Kocuria palustris 19C38A1 against Fusarium oxysporum
GB2430293A (en) Electronic sock sorting and mating system
Davoodian et al. Hysterangiales revisited: expanded phylogeny reveals new genera and two new suborders
Savoldelli et al. Biological risk assessment in the History and Historical Documentation Library of the University of Milan
WO2002039109A3 (fr) Procede de detection de cellules hematopoietiques humaines capables de reconstitution a court terme
EA200300643A1 (ru) Способ и устройство обработки сейсмических данных
Rymuszka et al. Comparative studies on the cytotoxic effects induced by nodularin in primary carp leukocytes and the cells of the fish CLC line
Molaei et al. A nine-legged tick: report of a morphological anomaly in the blacklegged tick, Ixodes scapularis (Acari: Ixodidae) from the northeastern United States
Comparato Filho et al. Rapid identification of Paracoccidioides lutzii and P. brasiliensis using Fourier Transform Infrared spectroscopy
Sakai et al. A review of the species of the genus Thalassina (Thalassinidea, Thalassinidae)
Nguyen Fungal hyphosphere microbiomes are distinct from surrounding substrates and show consistent association patterns
DE50213290D1 (de) Erfassung von signalen biologischen ursprungs
ZA99362B (en) EF-Tu mRNA as a marker for viability of bacteria.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2428107

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10416147

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP